SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-20-000029
Filing Date
2020-11-06
Accepted
2020-11-06 12:53:55
Documents
90
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20200930.htm   iXBRL 10-Q 2538840
2 EX-31.1 exhibit311-30sep20x10q.htm EX-31.1 10228
3 EX-31.2 exhibit312-30sep20x10q.htm EX-31.2 10673
4 EX-32.1 exhibit321-30sep20x10q.htm EX-32.1 6515
  Complete submission text file 0001048477-20-000029.txt   11145614

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20200930.xsd EX-101.SCH 66312
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20200930_cal.xml EX-101.CAL 118992
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20200930_def.xml EX-101.DEF 351898
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20200930_lab.xml EX-101.LAB 764784
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20200930_pre.xml EX-101.PRE 520322
10 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20200930_htm.xml XML 2435637
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 201293435
SIC: 2834 Pharmaceutical Preparations